China · Delayed Price · Currency is CNY Hubei Goto Biopharm Statistics
Total Valuation
SHE:300966 has a market cap or net worth of CNY 2.48 billion. The enterprise value is 3.74 billion.
| Market Cap | 2.48B |
| Enterprise Value | 3.74B |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300966 has 115.08 million shares outstanding. The number of shares has decreased by -4.04% in one year.
| Current Share Class | 115.08M |
| Shares Outstanding | 115.08M |
| Shares Change (YoY) | -4.04% |
| Shares Change (QoQ) | +8.38% |
| Owned by Insiders (%) | 44.74% |
| Owned by Institutions (%) | 2.32% |
| Float | 54.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.97 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 3.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 73.41, with an EV/FCF ratio of -15.35.
| EV / Earnings | -81.64 |
| EV / Sales | 5.98 |
| EV / EBITDA | 73.41 |
| EV / EBIT | n/a |
| EV / FCF | -15.35 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.32.
| Current Ratio | 1.02 |
| Quick Ratio | 0.39 |
| Debt / Equity | 1.32 |
| Debt / EBITDA | 24.88 |
| Debt / FCF | -5.20 |
| Interest Coverage | -0.11 |
Financial Efficiency
Return on equity (ROE) is -5.28% and return on invested capital (ROIC) is -0.22%.
| Return on Equity (ROE) | -5.28% |
| Return on Assets (ROA) | -0.10% |
| Return on Invested Capital (ROIC) | -0.22% |
| Return on Capital Employed (ROCE) | -0.22% |
| Weighted Average Cost of Capital (WACC) | 4.61% |
| Revenue Per Employee | 766,557 |
| Profits Per Employee | -56,137 |
| Employee Count | 817 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 1.17 |
Taxes
| Income Tax | -20.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.76% in the last 52 weeks. The beta is 0.24, so SHE:300966's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +42.76% |
| 50-Day Moving Average | 20.88 |
| 200-Day Moving Average | 20.17 |
| Relative Strength Index (RSI) | 60.17 |
| Average Volume (20 Days) | 1,835,525 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300966 had revenue of CNY 626.28 million and -45.86 million in losses. Loss per share was -0.40.
| Revenue | 626.28M |
| Gross Profit | 133.06M |
| Operating Income | -4.62M |
| Pretax Income | -72.86M |
| Net Income | -45.86M |
| EBITDA | 50.74M |
| EBIT | -4.62M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 94.66 million in cash and 1.27 billion in debt, with a net cash position of -1.17 billion or -10.20 per share.
| Cash & Cash Equivalents | 94.66M |
| Total Debt | 1.27B |
| Net Cash | -1.17B |
| Net Cash Per Share | -10.20 |
| Equity (Book Value) | 957.91M |
| Book Value Per Share | 7.00 |
| Working Capital | 16.85M |
Cash Flow
In the last 12 months, operating cash flow was -120.03 million and capital expenditures -123.90 million, giving a free cash flow of -243.93 million.
| Operating Cash Flow | -120.03M |
| Capital Expenditures | -123.90M |
| Free Cash Flow | -243.93M |
| FCF Per Share | -2.12 |
Margins
Gross margin is 21.25%, with operating and profit margins of -0.74% and -7.32%.
| Gross Margin | 21.25% |
| Operating Margin | -0.74% |
| Pretax Margin | -11.63% |
| Profit Margin | -7.32% |
| EBITDA Margin | 8.10% |
| EBIT Margin | -0.74% |
| FCF Margin | n/a |
Dividends & Yields
SHE:300966 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.04% |
| Shareholder Yield | 4.04% |
| Earnings Yield | -1.85% |
| FCF Yield | -9.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300966 has an Altman Z-Score of 1.03 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.03 |
| Piotroski F-Score | 3 |